Adverse events and drug–drug interactions of sodium glucose co-transporter 2 inhibitors in patients treated for heart failure

C Stöllberger, J Finsterer… - Expert Review of …, 2023 - Taylor & Francis
Introduction Sodium glucose co-transporter 2-inhibitors (SGLT2-I), antihyperglycemic
agents, are increasingly prescribed in chronic heart failure (CHF). Their risk for drug–drug …

Adverse events and drug-drug interactions of sodium glucose co-transporter 2 inhibitors in patients treated for heart failure

C Stöllberger, J Finsterer… - Expert review of … - pubmed.ncbi.nlm.nih.gov
Introduction Sodium glucoseco-transporter2-inhibitors (SGLT2-I), antihyperglycemic agents,
are increasinglyprescribed in chronic heart failure (CHF). Their risk for drug-drug …

Adverse events and drug-drug interactions of sodium glucose co-transporter 2 inhibitors in patients treated for heart failure.

C Stöllberger, J Finsterer… - Expert Review of …, 2023 - europepmc.org
Sodium glucoseco-transporter2-inhibitors (SGLT2-I), antihyperglycemic agents, are
increasinglyprescribed in chronic heart failure (CHF). Their risk for drug-drug interactions …